Insider Trading & Ownership - Garland Jonathan Todd

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Garland Jonathan Todd

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-05-06
Exercise
2024-05-08
8:48 pm
N/A
N/A
NanoString Technologies IncNSTGGarland Jonathan Todd
Chief Commercial Officer
200,000$0200,000
(Direct)
View
2023-08-28
Option Award
2023-08-28
4:26 pm
N/A
N/A
NanoString Technologies IncNSTGGarland Jonathan Todd
Chief Commercial Officer
200,000$0200,000
(Direct)
View
2023-08-18
Exercise
2023-08-21
8:10 pm
N/A
N/A
Cytek Biosciences Inc.CTKBGarland Jonathan Todd
Chief Commercial Officer
4,712$069,804
(Direct)
View
2023-08-18
Tax Withholding
2023-08-21
8:10 pm
N/A
N/A
Cytek Biosciences Inc.CTKBGarland Jonathan Todd
Chief Commercial Officer
1,836$8.4669,804
(Direct)
View
2023-05-18
Tax Withholding
2023-05-19
7:02 pm
N/A
N/A
Cytek Biosciences Inc.CTKBGarland Jonathan Todd
Chief Commercial Officer
3,757$6.6971,640
(Direct)
View
2023-05-18
Exercise
2023-05-19
7:02 pm
N/A
N/A
Cytek Biosciences Inc.CTKBGarland Jonathan Todd
Chief Commercial Officer
9,644$071,640
(Direct)
View
2023-03-03
Option Award
2023-03-07
7:45 pm
N/A
2033-03-03
Cytek Biosciences Inc.CTKBGarland Jonathan Todd
Chief Commercial Officer
110,953$0110,953
(Direct)
View
2022-04-25
Option Award
2022-04-27
8:07 pm
N/A
2032-04-25
Cytek Biosciences Inc.CTKBGarland Jonathan Todd
Chief Commercial Officer
78,188$078,188
(Direct)
View